Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» APD334
APD334
Arena Investors Hope Celgene Trial A Harbinger For Future Returns
Seeking Alpha
Sat, 03/19/16 - 01:52 pm
Arena Pharmaceuticals
Celgene
ozanimod
APD334
ulcerative colitis
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
The Arena Pipeline Potential
Seeking Alpha
Fri, 05/31/13 - 12:59 pm
Arena Pharmaceuticals
Belviq
Vivus
APD811
pulmonary hypertension
Termanogrel
deep vein thrombosis
APD334
autoimmune disease
Patients Dosed in Arena Study
Yahoo/Zacks
Wed, 04/10/13 - 11:20 am
Arena Pharmaceuticals
APD334
autoimmune disease
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
Yahoo
Fri, 04/5/13 - 11:05 am
Arena Pharmaceuticals
autoimmune disease
APD334